Global Veterinary Biomarkers Market By Animal Type (Companion Animals – Dogs, Cats, Others, Farm Animals – Cattle, Swine, Poultry, Horse, Others); By Product Type (Testing Kits, Reagents); By Diseases Type (Inflammatory Diseases, Infectious Diseases, Cardiovascular Diseases, Tumors, Others); By End Users (Veterinary Hospitals, Veterinary Clinics, Research Centers, Others); By Department (HR, Finance/Accounting, IT, Sales/Marketing, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
In terms of revenue, global veterinary biomarkers market was valued at US$ 716.92 Mn in 2021, growing at an estimated CAGR of 12.7% over the forecast period. Animals are an important part of human society. Two of the nature’s important creatures have been co-existing since ages. Right from farming to food, animals have been integral part of our lives. Veterinary biomarkers are used to safeguard animals. Rising cases of chronic diseases like cardiovascular ailments and cancer is driving the growth of the veterinary biomarkers market. Assay diagnostic kits that are based on biomarkers help in the prediction of the several diseases in its early stages. Also the fact that several research and development activities are being conducted in an attempt to enhance biomarker usages and this too contributes to the veterinary biomarkers market’s growth.
The growth of the veterinary biomarkers market was immensely impacted in a negative way due to the coronavirus pandemic. Major reason behind this fall was lockdown curbs imposed across the globe to curtail the spread of the dreadful infection. Owing to this, veterinary services were called off and this is why many pet or animal owners could seek treatment for their animals.
Animal Type Outlook
On the basis of animal type, the veterinary biomarkers market has been divided into companion animals and farm animals. While the companion animals’ segment is further bifurcated into dogs, cats and animals, the farm animals are categorised into cattle, swine, poultry, horse and others. The companion animals segment accounts for majority of revenue generated by this market as dogs and cats are undoubtedly most preferred pet animals. Animal lovers or pet owners love their pets and leave no stone unturned to seek correct treatment for them or keep them away from any disease. Adoption of dogs is on a rise and this is also the reason why this segment is successful.
Global Veterinary Biomarkers Market Revenue & Forecast, (US$ Million), 2022 – 2030
Product Type Outlook
On the basis of product type, the veterinary biomarkers market has been segmented into testing kits and reagents. The testing kits segment dominates in terms of market share. This is mainly because, these testing kits help determine any potential disease which ensures that the animal gets required treatment. Due to the use of the testing kits, several chronic diseases like cancer and those linked to cardiovascular organs can be avoided.
Diseases Type Outlook
On the basis of diseases type, the veterinary biomarkers market has been bifurcated into inflammatory diseases, infectious diseases, cardiovascular diseases, tumors and others. Inflammatory diseases segment generates majority of revenue for this market. According to several reports, various types of infections are on a rise among both the types of animals i.e. companion animals and farm animals. Many leading governments are taking efforts to curb transmission of zoonotic diseases, and use of veterinary biomarkers is proving a great help for this.
End Users Outlook
The end users’ segment of the veterinary biomarkers market has been categorised into veterinary hospitals, veterinary clinics, research centers and others. Veterinary hospitals mint maximum account of revenue for this market. This is majorly because veterinary hospitals provide services to numerous pets or animals, that too continuously.
Region Outlook
On the basis of region, the Veterinary Biomarkers Market has been divided into Latin America, Europe, North America, Asia-Pacific and others. The region of North America accounts for majority of revenue generated by this market. The reason behind this is that animal owners in the region are more aware and can afford best quality veterinary treatment.
Competitive Landscape
The report provides both, qualitative and quantitative research of veterinary biomarkers market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the major players operating in the global veterinary biomarkers market are listed below:
- ACUVET BIOTECH
- Antech Diagnostics, Inc.
- Avacta Animal Health Limited
- COBO SCIENTIFIC ApS
- Diapharma
- Life Diagnostics
- Mercodia AB
- Veterinary Biomarkers, Inc.
- Zoetis
- Other Market Participants
Global Veterinary Biomarkers Market
By Animal Type
- Companion animals
- Dogs
- Cats
- Others
- Farm Animals
- Cattle
- Swine
- Poultry
- Horse
- Others
By Product Type
- Testing Kits
- Reagents
By Diseases Type
- Inflammatory Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Tumors
- Others
By End Users
- Veterinary Hospitals
- Veterinary Clinics
- Research Centers
- Others
By Region
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1.
Historic
Years: 2015 - 2020
1.2.2.
Base
Year: 2021
1.2.3.
Forecast
Years: 2022 – 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1.
Research
Questionnaire
3.1.2.
Global
Percentage Breakdown
3.1.3.
Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary Research
3.2.1.
Paid
Databases
3.2.2.
Secondary
Sources
3.3. Market Size Estimates
3.3.1.
Top-Down
Approach
3.3.2.
Bottom-Up
Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Veterinary Biomarkers Market
6.
Market
Synopsis: Veterinary Biomarkers Market
7.
Veterinary
Biomarkers Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1.
Product
Definition
7.1.2.
Industry
Development
7.2. Market Dynamics
7.2.1.
Drivers
7.2.2.
Restraints
7.2.3.
Opportunities
7.2.4.
Challenges
7.3. Trends in Veterinary Biomarkers Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Veterinary Biomarkers Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Veterinary Biomarkers
Market
8.
Global Veterinary
Biomarkers Market Analysis and Forecasts, 2022 – 2030
8.1. Overview
8.1.1.
Global Veterinary
Biomarkers Market Revenue (US$ Mn)
8.2. Global Veterinary Biomarkers Market Revenue
(US$ Mn) and Forecasts, By Animal Type
8.2.1.
Companion
Animals (Definition, Market Estimation and Penetration, 2015 - 2021, Market
Estimation (2015 - 2021), Market Forecast (2022 - 2030), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on Dogs, Cats, Others)
8.2.1.1.
Dogs
8.2.1.2.
Cats
8.2.1.3.
Others
8.2.2.
Farm Animals
(Definition, Market Estimation and Penetration, 2015 - 2021, Market Estimation
(2015 - 2021), Market Forecast (2022 - 2030), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Cattle, Swine, Poultry, Horse,
Others)
8.2.2.1.
Cattle
8.2.2.2.
Swine
8.2.2.3.
Poultry
8.2.2.4.
Horse
8.2.2.5.
Others
8.3. Key Segment for Channeling Investments
8.3.1.
By
Animal Type
9.
Global Veterinary
Biomarkers Market Analysis and Forecasts, 2022 – 2030
9.1. Overview
9.2. Global Veterinary Biomarkers Market Revenue
(US$ Mn) and Forecasts, By Product Type
9.2.1.
Testing
kits
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.1.3.
Market
Forecast, 2022 - 2030
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1. Market Estimation, 2015 - 2021
9.2.1.5.1.2. Market Forecast, 2022 - 2030
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2021
9.2.1.5.2.2. Market Forecast, 2022 - 2030
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2021
9.2.1.5.3.2. Market Forecast, 2022 - 2030
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2021
9.2.1.5.4.2. Market Forecast, 2022 - 2030
9.2.1.5.5.
Latin
America
9.2.1.5.5.1. Market Estimation, 2015 - 2021
9.2.1.5.5.2. Market Forecast, 2022 - 2030
9.2.2.
Reagents
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.2.3.
Market
Forecast, 2022 - 2030
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2021
9.2.2.5.1.2. Market Forecast, 2022 - 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2021
9.2.2.5.2.2. Market Forecast, 2022 - 2030
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2021
9.2.2.5.3.2. Market Forecast, 2022 - 2030
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2021
9.2.2.5.4.2. Market Forecast, 2022 - 2030
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2021
9.2.2.5.5.2. Market Forecast, 2022 - 2030
9.3. Key Segment for Channeling Investments
9.3.1.
By
Product Type
10. Global Veterinary Biomarkers Market Analysis
and Forecasts, 2022 – 2030
10.1. Overview
10.2. Global Veterinary Biomarkers Market Revenue
(US$ Mn) and Forecasts, By Diseases Type
10.2.1. Inflammatory Diseases
10.2.1.1.
Definition
10.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.1.3.
Market
Forecast, 2022 - 2030
10.2.1.4.
Compound
Annual Growth Rate (CAGR)
10.2.1.5.
Regional
Bifurcation
10.2.1.5.1.
North
America
10.2.1.5.1.1. Market Estimation, 2015 - 2021
10.2.1.5.1.2. Market Forecast, 2022 - 2030
10.2.1.5.2.
Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2021
10.2.1.5.2.2. Market Forecast, 2022 - 2030
10.2.1.5.3.
Asia
Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2021
10.2.1.5.3.2. Market Forecast, 2022 - 2030
10.2.1.5.4.
Middle
East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2021
10.2.1.5.4.2. Market Forecast, 2022 - 2030
10.2.1.5.5.
Latin
America
10.2.1.5.5.1. Market Estimation, 2015 - 2021
10.2.1.5.5.2. Market Forecast, 2022 - 2030
10.2.2. Infectious Diseases
10.2.2.1.
Definition
10.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.2.3.
Market
Forecast, 2022 - 2030
10.2.2.4.
Compound
Annual Growth Rate (CAGR)
10.2.2.5.
Regional
Bifurcation
10.2.2.5.1.
North
America
10.2.2.5.1.1. Market Estimation, 2015 - 2021
10.2.2.5.1.2. Market Forecast, 2022 - 2030
10.2.2.5.2.
Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2021
10.2.2.5.2.2. Market Forecast, 2022 - 2030
10.2.2.5.3.
Asia
Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2021
10.2.2.5.3.2. Market Forecast, 2022 - 2030
10.2.2.5.4.
Middle
East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2021
10.2.2.5.4.2. Market Forecast, 2022 - 2030
10.2.2.5.5.
Latin
America
10.2.2.5.5.1. Market Estimation, 2015 - 2021
10.2.2.5.5.2. Market Forecast, 2022 - 2030
10.2.3. Cardiovascular Diseases
10.2.3.1.
Definition
10.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.3.3.
Market
Forecast, 2022 - 2030
10.2.3.4.
Compound
Annual Growth Rate (CAGR)
10.2.3.5.
Regional
Bifurcation
10.2.3.5.1.
North
America
10.2.3.5.1.1. Market Estimation, 2015 - 2021
10.2.3.5.1.2. Market Forecast, 2022 - 2030
10.2.3.5.2.
Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2021
10.2.3.5.2.2. Market Forecast, 2022 - 2030
10.2.3.5.3.
Asia
Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2021
10.2.3.5.3.2. Market Forecast, 2022 - 2030
10.2.3.5.4.
Middle
East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2021
10.2.3.5.4.2. Market Forecast, 2022 - 2030
10.2.3.5.5.
Latin
America
10.2.3.5.5.1. Market Estimation, 2015 - 2021
10.2.3.5.5.2. Market Forecast, 2022 - 2030
10.2.4. Tumors
10.2.4.1.
Definition
10.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.4.3.
Market
Forecast, 2022 - 2030
10.2.4.4.
Compound
Annual Growth Rate (CAGR)
10.2.4.5.
Regional
Bifurcation
10.2.4.5.1.
North
America
10.2.4.5.1.1. Market Estimation, 2015 - 2021
10.2.4.5.1.2. Market Forecast, 2022 - 2030
10.2.4.5.2.
Europe
10.2.4.5.2.1. Market Estimation, 2015 - 2021
10.2.4.5.2.2. Market Forecast, 2022 - 2030
10.2.4.5.3.
Asia
Pacific
10.2.4.5.3.1. Market Estimation, 2015 - 2021
10.2.4.5.3.2. Market Forecast, 2022 - 2030
10.2.4.5.4.
Middle
East and Africa
10.2.4.5.4.1. Market Estimation, 2015 - 2021
10.2.4.5.4.2. Market Forecast, 2022 - 2030
10.2.4.5.5.
Latin
America
10.2.4.5.5.1. Market Estimation, 2015 - 2021
10.2.4.5.5.2. Market Forecast, 2022 - 2030
10.2.5. Others
10.2.5.1.
Definition
10.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.5.3.
Market
Forecast, 2022 - 2030
10.2.5.4.
Compound
Annual Growth Rate (CAGR)
10.2.5.5.
Regional
Bifurcation
10.2.5.5.1.
North
America
10.2.5.5.1.1. Market Estimation, 2015 - 2021
10.2.5.5.1.2. Market Forecast, 2022 - 2030
10.2.5.5.2.
Europe
10.2.5.5.2.1. Market Estimation, 2015 - 2021
10.2.5.5.2.2. Market Forecast, 2022 - 2030
10.2.5.5.3.
Asia
Pacific
10.2.5.5.3.1. Market Estimation, 2015 - 2021
10.2.5.5.3.2. Market Forecast, 2022 - 2030
10.2.5.5.4.
Middle
East and Africa
10.2.5.5.4.1. Market Estimation, 2015 - 2021
10.2.5.5.4.2. Market Forecast, 2022 - 2030
10.2.5.5.5.
Latin
America
10.2.5.5.5.1. Market Estimation, 2015 - 2021
10.2.5.5.5.2. Market Forecast, 2022 - 2030
10.3. Key Segment for Channeling Investments
10.3.1. By Diseases Type
11. Global Veterinary Biomarkers Market Analysis
and Forecasts, 2022 – 2030
11.1. Overview
11.2. Global Veterinary Biomarkers Market Revenue
(US$ Mn) and Forecasts, By End Users
11.2.1. Veterinary Hospitals
11.2.1.1.
Definition
11.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.1.3.
Market
Forecast, 2022 - 2030
11.2.1.4.
Compound
Annual Growth Rate (CAGR)
11.2.1.5.
Regional
Bifurcation
11.2.1.5.1.
North
America
11.2.1.5.1.1. Market Estimation, 2015 - 2021
11.2.1.5.1.2. Market Forecast, 2022 - 2030
11.2.1.5.2.
Europe
11.2.1.5.2.1. Market Estimation, 2015 - 2021
11.2.1.5.2.2. Market Forecast, 2022 - 2030
11.2.1.5.3.
Asia
Pacific
11.2.1.5.3.1. Market Estimation, 2015 - 2021
11.2.1.5.3.2. Market Forecast, 2022 - 2030
11.2.1.5.4.
Middle
East and Africa
11.2.1.5.4.1. Market Estimation, 2015 - 2021
11.2.1.5.4.2. Market Forecast, 2022 - 2030
11.2.1.5.5.
Latin
America
11.2.1.5.5.1. Market Estimation, 2015 - 2021
11.2.1.5.5.2. Market Forecast, 2022 - 2030
11.2.2. Veterinary Clinics
11.2.2.1.
Definition
11.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.2.3.
Market
Forecast, 2022 - 2030
11.2.2.4.
Compound
Annual Growth Rate (CAGR)
11.2.2.5.
Regional
Bifurcation
11.2.2.5.1.
North
America
11.2.2.5.1.1. Market Estimation, 2015 - 2021
11.2.2.5.1.2. Market Forecast, 2022 - 2030
11.2.2.5.2.
Europe
11.2.2.5.2.1. Market Estimation, 2015 - 2021
11.2.2.5.2.2. Market Forecast, 2022 - 2030
11.2.2.5.3.
Asia
Pacific
11.2.2.5.3.1. Market Estimation, 2015 - 2021
11.2.2.5.3.2. Market Forecast, 2022 - 2030
11.2.2.5.4.
Middle
East and Africa
11.2.2.5.4.1. Market Estimation, 2015 - 2021
11.2.2.5.4.2. Market Forecast, 2022 - 2030
11.2.2.5.5.
Latin
America
11.2.2.5.5.1. Market Estimation, 2015 - 2021
11.2.2.5.5.2. Market Forecast, 2022 - 2030
11.2.3. Research Centers
11.2.3.1.
Definition
11.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.3.3.
Market
Forecast, 2022 - 2030
11.2.3.4.
Compound
Annual Growth Rate (CAGR)
11.2.3.5.
Regional
Bifurcation
11.2.3.5.1.
North
America
11.2.3.5.1.1. Market Estimation, 2015 - 2021
11.2.3.5.1.2. Market Forecast, 2022 - 2030
11.2.3.5.2.
Europe
11.2.3.5.2.1. Market Estimation, 2015 - 2021
11.2.3.5.2.2. Market Forecast, 2022 - 2030
11.2.3.5.3.
Asia
Pacific
11.2.3.5.3.1. Market Estimation, 2015 - 2021
11.2.3.5.3.2. Market Forecast, 2022 - 2030
11.2.3.5.4.
Middle
East and Africa
11.2.3.5.4.1. Market Estimation, 2015 - 2021
11.2.3.5.4.2. Market Forecast, 2022 - 2030
11.2.3.5.5.
Latin
America
11.2.3.5.5.1. Market Estimation, 2015 - 2021
11.2.3.5.5.2. Market Forecast, 2022 - 2030
11.2.4. Others
11.2.4.1.
Definition
11.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.4.3.
Market
Forecast, 2022 - 2030
11.2.4.4.
Compound
Annual Growth Rate (CAGR)
11.2.4.5.
Regional
Bifurcation
11.2.4.5.1.
North
America
11.2.4.5.1.1. Market Estimation, 2015 - 2021
11.2.4.5.1.2. Market Forecast, 2022 - 2030
11.2.4.5.2.
Europe
11.2.4.5.2.1. Market Estimation, 2015 - 2021
11.2.4.5.2.2. Market Forecast, 2022 - 2030
11.2.4.5.3.
Asia
Pacific
11.2.4.5.3.1. Market Estimation, 2015 - 2021
11.2.4.5.3.2. Market Forecast, 2022 - 2030
11.2.4.5.4.
Middle
East and Africa
11.2.4.5.4.1. Market Estimation, 2015 - 2021
11.2.4.5.4.2. Market Forecast, 2022 - 2030
11.2.4.5.5.
Latin
America
11.2.4.5.5.1. Market Estimation, 2015 - 2021
11.2.4.5.5.2. Market Forecast, 2022 - 2030
11.3. Key Segment for Channeling Investments
11.3.1. By End Users
12. North America Veterinary Biomarkers Market
Analysis and Forecasts, 2022 - 2030
12.1. Overview
12.1.1. North America Veterinary Biomarkers Market
Revenue (US$ Mn)
12.2. North America Veterinary Biomarkers Market
Revenue (US$ Mn) and Forecasts, By Animal Type
12.2.1. Companion Animals
12.2.1.1.
Dogs
12.2.1.2.
Cats
12.2.1.3.
Others
12.2.2. Farm Animals
12.2.2.1.
Cattle
12.2.2.2.
Swine
12.2.2.3.
Poultry
12.2.2.4.
Horse
12.2.2.5.
Others
12.3. North America Veterinary Biomarkers Market
Revenue (US$ Mn) and Forecasts, By Product Type
12.3.1. Testing kits
12.3.2. Reagents
12.4. North America Veterinary Biomarkers Market
Revenue (US$ Mn) and Forecasts, By Diseases Type
12.4.1. Inflammatory Diseases
12.4.2. Infectious Diseases
12.4.3. Cardiovascular Diseases
12.4.4. Tumors
12.4.5. Others
12.5. North America Veterinary Biomarkers Market
Revenue (US$ Mn) and Forecasts, By End Users
12.5.1. Veterinary Hospitals
12.5.2. Veterinary Clinics
12.5.3. Research Centers
12.5.4. Others
12.6. North America Veterinary Biomarkers Market
Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1.
U.S Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal Type
12.6.1.1.1.
Companion
Animals
12.6.1.1.1.1. Dogs
12.6.1.1.1.2. Cats
12.6.1.1.1.3. Others
12.6.1.1.2.
Farm
Animals
12.6.1.1.2.1. Cattle
12.6.1.1.2.2. Swine
12.6.1.1.2.3. Poultry
12.6.1.1.2.4. Horse
12.6.1.1.2.5. Others
12.6.1.2.
U.S Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product Type
12.6.1.2.1.
Testing
kits
12.6.1.2.2.
Reagents
12.6.1.3.
U.S Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases Type
12.6.1.3.1.
Inflammatory
Diseases
12.6.1.3.2.
Infectious
Diseases
12.6.1.3.3.
Cardiovascular
Diseases
12.6.1.3.4.
Tumors
12.6.1.3.5.
Others
12.6.1.4.
U.S Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.1.4.1.
Veterinary
Hospitals
12.6.1.4.2.
Veterinary
Clinics
12.6.1.4.3.
Research
Centers
12.6.1.4.4.
Others
12.6.2. Canada
12.6.2.1.
Canada Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal Type
12.6.2.1.1.
Companion
Animals
12.6.2.1.1.1. Dogs
12.6.2.1.1.2. Cats
12.6.2.1.1.3. Others
12.6.2.1.2.
Farm
Animals
12.6.2.1.2.1. Cattle
12.6.2.1.2.2. Swine
12.6.2.1.2.3. Poultry
12.6.2.1.2.4. Horse
12.6.2.1.2.5. Others
12.6.2.2.
Canada Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product Type
12.6.2.2.1.
Testing
kits
12.6.2.2.2.
Reagents
12.6.2.3.
Canada Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases Type
12.6.2.3.1.
Inflammatory
Diseases
12.6.2.3.2.
Infectious
Diseases
12.6.2.3.3.
Cardiovascular
Diseases
12.6.2.3.4.
Tumors
12.6.2.3.5.
Others
12.6.2.4.
Canada Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.2.4.1.
Veterinary
Hospitals
12.6.2.4.2.
Veterinary
Clinics
12.6.2.4.3.
Research
Centers
12.6.2.4.4.
Others
12.6.3. Mexico
12.6.3.1.
Mexico Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal Type
12.6.3.1.1.
Companion
Animals
12.6.3.1.1.1. Dogs
12.6.3.1.1.2. Cats
12.6.3.1.1.3. Others
12.6.3.1.2.
Farm
Animals
12.6.3.1.2.1. Cattle
12.6.3.1.2.2. Swine
12.6.3.1.2.3. Poultry
12.6.3.1.2.4. Horse
12.6.3.1.2.5. Others
12.6.3.2.
Mexico Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product Type
12.6.3.2.1.
Testing
kits
12.6.3.2.2.
Reagents
12.6.3.3.
Mexico Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases Type
12.6.3.3.1.
Inflammatory
Diseases
12.6.3.3.2.
Infectious
Diseases
12.6.3.3.3.
Cardiovascular
Diseases
12.6.3.3.4.
Tumors
12.6.3.3.5.
Others
12.6.3.4.
Mexico Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.3.4.1.
Veterinary
Hospitals
12.6.3.4.2.
Veterinary
Clinics
12.6.3.4.3.
Research
Centers
12.6.3.4.4.
Others
12.6.4. Rest of North America
12.6.4.1.
Rest of
North America Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Animal Type
12.6.4.1.1.
Companion
Animals
12.6.4.1.1.1. Dogs
12.6.4.1.1.2. Cats
12.6.4.1.1.3. Others
12.6.4.1.2.
Farm
Animals
12.6.4.1.2.1. Cattle
12.6.4.1.2.2. Swine
12.6.4.1.2.3. Poultry
12.6.4.1.2.4. Horse
12.6.4.1.2.5. Others
12.6.4.2.
Rest of
North America Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Product Type
12.6.4.2.1.
Testing
kits
12.6.4.2.2.
Reagents
12.6.4.3.
Rest of
North America Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Diseases Type
12.6.4.3.1.
Inflammatory
Diseases
12.6.4.3.2.
Infectious
Diseases
12.6.4.3.3.
Cardiovascular
Diseases
12.6.4.3.4.
Tumors
12.6.4.3.5.
Others
12.6.4.4.
Rest of
North America Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By
End Users
12.6.4.4.1.
Veterinary
Hospitals
12.6.4.4.2.
Veterinary
Clinics
12.6.4.4.3.
Research
Centers
12.6.4.4.4.
Others
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Animal Type
12.7.3. By Product Type
12.7.4. By Diseases Type
12.7.5. By End Users
13. Europe Veterinary Biomarkers Market Analysis
and Forecasts, 2022 - 2030
13.1. Overview
13.1.1. Europe Veterinary Biomarkers Market Revenue
(US$ Mn)
13.2. Europe Veterinary Biomarkers Market Revenue
(US$ Mn) and Forecasts, By Animal Type
13.2.1. Companion Animals
13.2.1.1.
Dogs
13.2.1.2.
Cats
13.2.1.3.
Others
13.2.2. Farm Animals
13.2.2.1.
Cattle
13.2.2.2.
Swine
13.2.2.3.
Poultry
13.2.2.4.
Horse
13.2.2.5.
Others
13.3. Europe Veterinary Biomarkers Market Revenue
(US$ Mn) and Forecasts, By Product Type
13.3.1. Testing kits
13.3.2. Reagents
13.4. Europe Veterinary Biomarkers Market Revenue
(US$ Mn) and Forecasts, By Diseases Type
13.4.1. Inflammatory Diseases
13.4.2. Infectious Diseases
13.4.3. Cardiovascular Diseases
13.4.4. Tumors
13.4.5. Others
13.5. Europe Veterinary Biomarkers Market Revenue
(US$ Mn) and Forecasts, By End Users
13.5.1. Veterinary Hospitals
13.5.2. Veterinary Clinics
13.5.3. Research Centers
13.5.4. Others
13.6. Europe Veterinary Biomarkers Market Revenue
(US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1.
France Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal Type
13.6.1.1.1.
Companion
Animals
13.6.1.1.1.1. Dogs
13.6.1.1.1.2. Cats
13.6.1.1.1.3. Others
13.6.1.1.2.
Farm
Animals
13.6.1.1.2.1. Cattle
13.6.1.1.2.2. Swine
13.6.1.1.2.3. Poultry
13.6.1.1.2.4. Horse
13.6.1.1.2.5. Others
13.6.1.2.
France Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product Type
13.6.1.2.1.
Testing
kits
13.6.1.2.2.
Reagents
13.6.1.3.
France Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases Type
13.6.1.3.1.
Inflammatory
Diseases
13.6.1.3.2.
Infectious
Diseases
13.6.1.3.3.
Cardiovascular
Diseases
13.6.1.3.4.
Tumors
13.6.1.3.5.
Others
13.6.1.4.
France Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.1.4.1.
Veterinary
Hospitals
13.6.1.4.2.
Veterinary
Clinics
13.6.1.4.3.
Research
Centers
13.6.1.4.4.
Others
13.6.2. The UK
13.6.2.1.
The UK Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal Type
13.6.2.1.1.
Companion
Animals
13.6.2.1.1.1. Dogs
13.6.2.1.1.2. Cats
13.6.2.1.1.3. Others
13.6.2.1.2.
Farm
Animals
13.6.2.1.2.1. Cattle
13.6.2.1.2.2. Swine
13.6.2.1.2.3. Poultry
13.6.2.1.2.4. Horse
13.6.2.1.2.5. Others
13.6.2.2.
The UK Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product Type
13.6.2.2.1.
Testing
kits
13.6.2.2.2.
Reagents
13.6.2.3.
The UK Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases Type
13.6.2.3.1.
Inflammatory
Diseases
13.6.2.3.2.
Infectious
Diseases
13.6.2.3.3.
Cardiovascular
Diseases
13.6.2.3.4.
Tumors
13.6.2.3.5.
Others
13.6.2.4.
The UK Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.2.4.1.
Veterinary
Hospitals
13.6.2.4.2.
Veterinary
Clinics
13.6.2.4.3.
Research
Centers
13.6.2.4.4.
Others
13.6.3. Spain
13.6.3.1.
Spain Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal Type
13.6.3.1.1.
Companion
Animals
13.6.3.1.1.1. Dogs
13.6.3.1.1.2. Cats
13.6.3.1.1.3. Others
13.6.3.1.2.
Farm
Animals
13.6.3.1.2.1. Cattle
13.6.3.1.2.2. Swine
13.6.3.1.2.3. Poultry
13.6.3.1.2.4. Horse
13.6.3.1.2.5. Others
13.6.3.2.
Spain Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product Type
13.6.3.2.1.
Testing
kits
13.6.3.2.2.
Reagents
13.6.3.3.
Spain Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases Type
13.6.3.3.1.
Inflammatory
Diseases
13.6.3.3.2.
Infectious
Diseases
13.6.3.3.3.
Cardiovascular
Diseases
13.6.3.3.4.
Tumors
13.6.3.3.5.
Others
13.6.3.4.
Spain Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.3.4.1.
Veterinary
Hospitals
13.6.3.4.2.
Veterinary
Clinics
13.6.3.4.3.
Research
Centers
13.6.3.4.4.
Others
13.6.4. Germany
13.6.4.1.
Germany Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal Type
13.6.4.1.1.
Companion
Animals
13.6.4.1.1.1. Dogs
13.6.4.1.1.2. Cats
13.6.4.1.1.3. Others
13.6.4.1.2.
Farm
Animals
13.6.4.1.2.1. Cattle
13.6.4.1.2.2. Swine
13.6.4.1.2.3. Poultry
13.6.4.1.2.4. Horse
13.6.4.1.2.5. Others
13.6.4.2.
Germany Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product Type
13.6.4.2.1.
Testing
kits
13.6.4.2.2.
Reagents
13.6.4.3.
Germany Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases Type
13.6.4.3.1.
Inflammatory
Diseases
13.6.4.3.2.
Infectious
Diseases
13.6.4.3.3.
Cardiovascular
Diseases
13.6.4.3.4.
Tumors
13.6.4.3.5.
Others
13.6.4.4.
Germany Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.4.4.1.
Veterinary
Hospitals
13.6.4.4.2.
Veterinary
Clinics
13.6.4.4.3.
Research
Centers
13.6.4.4.4.
Others
13.6.5. Italy
13.6.5.1.
Italy Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal Type
13.6.5.1.1.
Companion
Animals
13.6.5.1.1.1. Dogs
13.6.5.1.1.2. Cats
13.6.5.1.1.3. Others
13.6.5.1.2.
Farm
Animals
13.6.5.1.2.1. Cattle
13.6.5.1.2.2. Swine
13.6.5.1.2.3. Poultry
13.6.5.1.2.4. Horse
13.6.5.1.2.5. Others
13.6.5.2.
Italy Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product Type
13.6.5.2.1.
Testing
kits
13.6.5.2.2.
Reagents
13.6.5.3.
Italy Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases Type
13.6.5.3.1.
Inflammatory
Diseases
13.6.5.3.2.
Infectious
Diseases
13.6.5.3.3.
Cardiovascular
Diseases
13.6.5.3.4.
Tumors
13.6.5.3.5.
Others
13.6.5.4.
Italy Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.5.4.1.
Veterinary
Hospitals
13.6.5.4.2.
Veterinary
Clinics
13.6.5.4.3.
Research
Centers
13.6.5.4.4.
Others
13.6.6. Nordic Countries
13.6.6.1.
Nordic
Countries Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Animal Type
13.6.6.1.1.
Companion
Animals
13.6.6.1.1.1. Dogs
13.6.6.1.1.2. Cats
13.6.6.1.1.3. Others
13.6.6.1.2.
Farm
Animals
13.6.6.1.2.1. Cattle
13.6.6.1.2.2. Swine
13.6.6.1.2.3. Poultry
13.6.6.1.2.4. Horse
13.6.6.1.2.5. Others
13.6.6.2.
Nordic
Countries Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Product Type
13.6.6.2.1.
Testing
kits
13.6.6.2.2.
Reagents
13.6.6.3.
Nordic
Countries Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Diseases Type
13.6.6.3.1.
Inflammatory
Diseases
13.6.6.3.2.
Infectious
Diseases
13.6.6.3.3.
Cardiovascular
Diseases
13.6.6.3.4.
Tumors
13.6.6.3.5.
Others
13.6.6.4.
Nordic
Countries Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By End
Users
13.6.6.4.1.
Veterinary
Hospitals
13.6.6.4.2.
Veterinary
Clinics
13.6.6.4.3.
Research
Centers
13.6.6.4.4.
Others
13.6.6.5.
Nordic
Countries Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Country
13.6.6.5.1.
Denmark
13.6.6.5.2.
Finland
13.6.6.5.3.
Iceland
13.6.6.5.4.
Sweden
13.6.6.5.5.
Norway
13.6.7. Benelux Union
13.6.7.1.
Benelux
Union Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal
Type
13.6.7.1.1.
Companion
Animals
13.6.7.1.1.1. Dogs
13.6.7.1.1.2. Cats
13.6.7.1.1.3. Others
13.6.7.1.2.
Farm
Animals
13.6.7.1.2.1. Cattle
13.6.7.1.2.2. Swine
13.6.7.1.2.3. Poultry
13.6.7.1.2.4. Horse
13.6.7.1.2.5. Others
13.6.7.2.
Benelux
Union Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product
Type
13.6.7.2.1.
Testing
kits
13.6.7.2.2.
Reagents
13.6.7.3.
Benelux
Union Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases
Type
13.6.7.3.1.
Inflammatory
Diseases
13.6.7.3.2.
Infectious
Diseases
13.6.7.3.3.
Cardiovascular
Diseases
13.6.7.3.4.
Tumors
13.6.7.3.5.
Others
13.6.7.4.
Benelux
Union Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.7.4.1.
Veterinary
Hospitals
13.6.7.4.2.
Veterinary
Clinics
13.6.7.4.3.
Research
Centers
13.6.7.4.4.
Others
13.6.7.5.
Benelux
Union Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Country
13.6.7.5.1.
Belgium
13.6.7.5.2.
The
Netherlands
13.6.7.5.3.
Luxembourg
13.6.8. Rest of Europe
13.6.8.1.
Rest of
Europe Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal
Type
13.6.8.1.1.
Companion
Animals
13.6.8.1.1.1. Dogs
13.6.8.1.1.2. Cats
13.6.8.1.1.3. Others
13.6.8.1.2.
Farm
Animals
13.6.8.1.2.1. Cattle
13.6.8.1.2.2. Swine
13.6.8.1.2.3. Poultry
13.6.8.1.2.4. Horse
13.6.8.1.2.5. Others
13.6.8.2.
Rest of
Europe Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product
Type
13.6.8.2.1.
Testing
kits
13.6.8.2.2.
Reagents
13.6.8.3.
Rest of
Europe Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases
Type
13.6.8.3.1.
Inflammatory
Diseases
13.6.8.3.2.
Infectious
Diseases
13.6.8.3.3.
Cardiovascular
Diseases
13.6.8.3.4.
Tumors
13.6.8.3.5.
Others
13.6.8.4.
Rest of
Europe Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By End
Users
13.6.8.4.1.
Veterinary
Hospitals
13.6.8.4.2.
Veterinary
Clinics
13.6.8.4.3.
Research
Centers
13.6.8.4.4.
Others
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Animal Type
13.7.3. By Product Type
13.7.4. By Diseases Type
13.7.5. By End Users
14. Asia Pacific Veterinary Biomarkers Market
Analysis and Forecasts, 2022 - 2030
14.1. Overview
14.1.1. Asia Pacific Veterinary Biomarkers Market
Revenue (US$ Mn)
14.2. Asia Pacific Veterinary Biomarkers Market
Revenue (US$ Mn) and Forecasts, By Animal Type
14.2.1. Companion Animals
14.2.1.1.
Dogs
14.2.1.2.
Cats
14.2.1.3.
Others
14.2.2. Farm Animals
14.2.2.1.
Cattle
14.2.2.2.
Swine
14.2.2.3.
Poultry
14.2.2.4.
Horse
14.2.2.5.
Others
14.3. Asia Pacific Veterinary Biomarkers Market
Revenue (US$ Mn) and Forecasts, By Product Type
14.3.1. Testing kits
14.3.2. Reagents
14.4. Asia Pacific Veterinary Biomarkers Market
Revenue (US$ Mn) and Forecasts, By Diseases Type
14.4.1. Inflammatory Diseases
14.4.2. Infectious Diseases
14.4.3. Cardiovascular Diseases
14.4.4. Tumors
14.4.5. Others
14.5. Asia Pacific Veterinary Biomarkers Market
Revenue (US$ Mn) and Forecasts, By End Users
14.5.1. Veterinary Hospitals
14.5.2. Veterinary Clinics
14.5.3. Research Centers
14.5.4. Others
14.6. Asia Pacific Veterinary Biomarkers Market
Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1.
China Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal Type
14.6.1.1.1.
Companion
Animals
14.6.1.1.1.1. Dogs
14.6.1.1.1.2. Cats
14.6.1.1.1.3. Others
14.6.1.1.2.
Farm
Animals
14.6.1.1.2.1. Cattle
14.6.1.1.2.2. Swine
14.6.1.1.2.3. Poultry
14.6.1.1.2.4. Horse
14.6.1.1.2.5. Others
14.6.1.2.
China Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product Type
14.6.1.2.1.
Testing
kits
14.6.1.2.2.
Reagents
14.6.1.3.
China Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases Type
14.6.1.3.1.
Inflammatory
Diseases
14.6.1.3.2.
Infectious
Diseases
14.6.1.3.3.
Cardiovascular
Diseases
14.6.1.3.4.
Tumors
14.6.1.3.5.
Others
14.6.1.4.
China Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.1.4.1.
Veterinary
Hospitals
14.6.1.4.2.
Veterinary
Clinics
14.6.1.4.3.
Research
Centers
14.6.1.4.4.
Others
14.6.2. Japan
14.6.2.1.
Japan Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal Type
14.6.2.1.1.
Companion
Animals
14.6.2.1.1.1. Dogs
14.6.2.1.1.2. Cats
14.6.2.1.1.3. Others
14.6.2.1.2.
Farm
Animals
14.6.2.1.2.1. Cattle
14.6.2.1.2.2. Swine
14.6.2.1.2.3. Poultry
14.6.2.1.2.4. Horse
14.6.2.1.2.5. Others
14.6.2.2.
Japan Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product Type
14.6.2.2.1.
Testing
kits
14.6.2.2.2.
Reagents
14.6.2.3.
Japan Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases Type
14.6.2.3.1.
Inflammatory
Diseases
14.6.2.3.2.
Infectious
Diseases
14.6.2.3.3.
Cardiovascular
Diseases
14.6.2.3.4.
Tumors
14.6.2.3.5.
Others
14.6.2.4.
Japan Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.2.4.1.
Veterinary
Hospitals
14.6.2.4.2.
Veterinary
Clinics
14.6.2.4.3.
Research
Centers
14.6.2.4.4.
Others
14.6.3. India
14.6.3.1.
India Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal Type
14.6.3.1.1.
Companion
Animals
14.6.3.1.1.1. Dogs
14.6.3.1.1.2. Cats
14.6.3.1.1.3. Others
14.6.3.1.2.
Farm
Animals
14.6.3.1.2.1. Cattle
14.6.3.1.2.2. Swine
14.6.3.1.2.3. Poultry
14.6.3.1.2.4. Horse
14.6.3.1.2.5. Others
14.6.3.2.
India Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product Type
14.6.3.2.1.
Testing
kits
14.6.3.2.2.
Reagents
14.6.3.3.
India Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases Type
14.6.3.3.1.
Inflammatory
Diseases
14.6.3.3.2.
Infectious
Diseases
14.6.3.3.3.
Cardiovascular
Diseases
14.6.3.3.4.
Tumors
14.6.3.3.5.
Others
14.6.3.4.
India Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.3.4.1.
Veterinary
Hospitals
14.6.3.4.2.
Veterinary
Clinics
14.6.3.4.3.
Research
Centers
14.6.3.4.4.
Others
14.6.4. New Zealand
14.6.4.1.
New
Zealand Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal
Type
14.6.4.1.1.
Companion
Animals
14.6.4.1.1.1. Dogs
14.6.4.1.1.2. Cats
14.6.4.1.1.3. Others
14.6.4.1.2.
Farm
Animals
14.6.4.1.2.1. Cattle
14.6.4.1.2.2. Swine
14.6.4.1.2.3. Poultry
14.6.4.1.2.4. Horse
14.6.4.1.2.5. Others
14.6.4.2.
New
Zealand Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product
Type
14.6.4.2.1.
Testing
kits
14.6.4.2.2.
Reagents
14.6.4.3.
New
Zealand Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Diseases Type
14.6.4.3.1.
Inflammatory
Diseases
14.6.4.3.2.
Infectious
Diseases
14.6.4.3.3.
Cardiovascular
Diseases
14.6.4.3.4.
Tumors
14.6.4.3.5.
Others
14.6.4.4.
New
Zealand Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By End
Users
14.6.4.4.1.
Veterinary
Hospitals
14.6.4.4.2.
Veterinary
Clinics
14.6.4.4.3.
Research
Centers
14.6.4.4.4.
Others
14.6.5. Australia
14.6.5.1.
Australia
Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal Type
14.6.5.1.1.
Companion
Animals
14.6.5.1.1.1. Dogs
14.6.5.1.1.2. Cats
14.6.5.1.1.3. Others
14.6.5.1.2.
Farm
Animals
14.6.5.1.2.1. Cattle
14.6.5.1.2.2. Swine
14.6.5.1.2.3. Poultry
14.6.5.1.2.4. Horse
14.6.5.1.2.5. Others
14.6.5.2.
Australia
Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product Type
14.6.5.2.1.
Testing
kits
14.6.5.2.2.
Reagents
14.6.5.3.
Australia
Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases Type
14.6.5.3.1.
Inflammatory
Diseases
14.6.5.3.2.
Infectious
Diseases
14.6.5.3.3.
Cardiovascular
Diseases
14.6.5.3.4.
Tumors
14.6.5.3.5.
Others
14.6.5.4.
Australia
Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.5.4.1.
Veterinary
Hospitals
14.6.5.4.2.
Veterinary
Clinics
14.6.5.4.3.
Research
Centers
14.6.5.4.4.
Others
14.6.6. South Korea
14.6.6.1.
South
Korea Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal
Type
14.6.6.1.1.
Companion
Animals
14.6.6.1.1.1. Dogs
14.6.6.1.1.2. Cats
14.6.6.1.1.3. Others
14.6.6.1.2.
Farm
Animals
14.6.6.1.2.1. Cattle
14.6.6.1.2.2. Swine
14.6.6.1.2.3. Poultry
14.6.6.1.2.4. Horse
14.6.6.1.2.5. Others
14.6.6.2.
South
Korea Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product
Type
14.6.6.2.1.
Testing
kits
14.6.6.2.2.
Reagents
14.6.6.3.
South
Korea Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases
Type
14.6.6.3.1.
Inflammatory
Diseases
14.6.6.3.2.
Infectious
Diseases
14.6.6.3.3.
Cardiovascular
Diseases
14.6.6.3.4.
Tumors
14.6.6.3.5.
Others
14.6.6.4.
South
Korea Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.6.4.1.
Veterinary
Hospitals
14.6.6.4.2.
Veterinary
Clinics
14.6.6.4.3.
Research
Centers
14.6.6.4.4.
Others
14.6.7. Southeast Asia
14.6.7.1.
Southeast
Asia Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal
Type
14.6.7.1.1.
Companion
Animals
14.6.7.1.1.1. Dogs
14.6.7.1.1.2. Cats
14.6.7.1.1.3. Others
14.6.7.1.2.
Farm
Animals
14.6.7.1.2.1. Cattle
14.6.7.1.2.2. Swine
14.6.7.1.2.3. Poultry
14.6.7.1.2.4. Horse
14.6.7.1.2.5. Others
14.6.7.2.
Southeast
Asia Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product
Type
14.6.7.2.1.
Testing
kits
14.6.7.2.2.
Reagents
14.6.7.3.
Southeast
Asia Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases
Type
14.6.7.3.1.
Inflammatory
Diseases
14.6.7.3.2.
Infectious
Diseases
14.6.7.3.3.
Cardiovascular
Diseases
14.6.7.3.4.
Tumors
14.6.7.3.5.
Others
14.6.7.4.
Southeast
Asia Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.7.4.1.
Veterinary
Hospitals
14.6.7.4.2.
Veterinary
Clinics
14.6.7.4.3.
Research
Centers
14.6.7.4.4.
Others
14.6.7.5.
Southeast
Asia Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Country
14.6.7.5.1.
Indonesia
14.6.7.5.2.
Thailand
14.6.7.5.3.
Malaysia
14.6.7.5.4.
Singapore
14.6.7.5.5.
Rest of
Southeast Asia
14.6.8. Rest of Asia Pacific
14.6.8.1.
Rest of
Asia Pacific Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Animal Type
14.6.8.1.1.
Companion
Animals
14.6.8.1.1.1. Dogs
14.6.8.1.1.2. Cats
14.6.8.1.1.3. Others
14.6.8.1.2.
Farm
Animals
14.6.8.1.2.1. Cattle
14.6.8.1.2.2. Swine
14.6.8.1.2.3. Poultry
14.6.8.1.2.4. Horse
14.6.8.1.2.5. Others
14.6.8.2.
Rest of
Asia Pacific Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Product Type
14.6.8.2.1.
Testing
kits
14.6.8.2.2.
Reagents
14.6.8.3.
Rest of
Asia Pacific Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Diseases Type
14.6.8.3.1.
Inflammatory
Diseases
14.6.8.3.2.
Infectious
Diseases
14.6.8.3.3.
Cardiovascular
Diseases
14.6.8.3.4.
Tumors
14.6.8.3.5.
Others
14.6.8.4.
Rest of
Asia Pacific Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By
End Users
14.6.8.4.1.
Veterinary
Hospitals
14.6.8.4.2.
Veterinary
Clinics
14.6.8.4.3.
Research
Centers
14.6.8.4.4.
Others
14.7. Key Segment for Channeling Investments
14.7.1. By Country
14.7.2. By Animal Type
14.7.3. By Product Type
14.7.4. By Diseases Type
14.7.5. By End Users
15. Middle East and Africa Veterinary Biomarkers
Market Analysis and Forecasts, 2022 - 2030
15.1. Overview
15.1.1. Middle East and Africa Veterinary Biomarkers
Market Revenue (US$ Mn)
15.2. Middle East and Africa Veterinary Biomarkers
Market Revenue (US$ Mn) and Forecasts, By Animal Type
15.2.1. Companion Animals
15.2.1.1.
Dogs
15.2.1.2.
Cats
15.2.1.3.
Others
15.2.2. Farm Animals
15.2.2.1.
Cattle
15.2.2.2.
Swine
15.2.2.3.
Poultry
15.2.2.4.
Horse
15.2.2.5.
Others
15.3. Middle East and Africa Veterinary Biomarkers
Market Revenue (US$ Mn) and Forecasts, By Product Type
15.3.1. Testing kits
15.3.2. Reagents
15.4. Middle East and Africa Veterinary Biomarkers
Market Revenue (US$ Mn) and Forecasts, By Diseases Type
15.4.1. Inflammatory Diseases
15.4.2. Infectious Diseases
15.4.3. Cardiovascular Diseases
15.4.4. Tumors
15.4.5. Others
15.5. Middle East and Africa Veterinary Biomarkers
Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.1. Veterinary Hospitals
15.5.2. Veterinary Clinics
15.5.3. Research Centers
15.5.4. Others
15.6. Middle East and Africa Veterinary Biomarkers
Market Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1.
Saudi
Arabia Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal
Type
15.6.1.1.1.
Companion
Animals
15.6.1.1.1.1. Dogs
15.6.1.1.1.2. Cats
15.6.1.1.1.3. Others
15.6.1.1.2.
Farm
Animals
15.6.1.1.2.1. Cattle
15.6.1.1.2.2. Swine
15.6.1.1.2.3. Poultry
15.6.1.1.2.4. Horse
15.6.1.1.2.5. Others
15.6.1.2.
Saudi
Arabia Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product
Type
15.6.1.2.1.
Testing
kits
15.6.1.2.2.
Reagents
15.6.1.3.
Saudi
Arabia Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases
Type
15.6.1.3.1.
Inflammatory
Diseases
15.6.1.3.2.
Infectious
Diseases
15.6.1.3.3.
Cardiovascular
Diseases
15.6.1.3.4.
Tumors
15.6.1.3.5.
Others
15.6.1.4.
Saudi
Arabia Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.1.4.1.
Veterinary
Hospitals
15.6.1.4.2.
Veterinary
Clinics
15.6.1.4.3.
Research
Centers
15.6.1.4.4.
Others
15.6.2. UAE
15.6.2.1.
UAE Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal Type
15.6.2.1.1.
Companion
Animals
15.6.2.1.1.1. Dogs
15.6.2.1.1.2. Cats
15.6.2.1.1.3. Others
15.6.2.1.2.
Farm
Animals
15.6.2.1.2.1. Cattle
15.6.2.1.2.2. Swine
15.6.2.1.2.3. Poultry
15.6.2.1.2.4. Horse
15.6.2.1.2.5. Others
15.6.2.2.
UAE Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product Type
15.6.2.2.1.
Testing
kits
15.6.2.2.2.
Reagents
15.6.2.3.
UAE Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases Type
15.6.2.3.1.
Inflammatory
Diseases
15.6.2.3.2.
Infectious
Diseases
15.6.2.3.3.
Cardiovascular
Diseases
15.6.2.3.4.
Tumors
15.6.2.3.5.
Others
15.6.2.4.
UAE Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.2.4.1.
Veterinary
Hospitals
15.6.2.4.2.
Veterinary
Clinics
15.6.2.4.3.
Research
Centers
15.6.2.4.4.
Others
15.6.3. Egypt
15.6.3.1.
Egypt Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal Type
15.6.3.1.1.
Companion
Animals
15.6.3.1.1.1. Dogs
15.6.3.1.1.2. Cats
15.6.3.1.1.3. Others
15.6.3.1.2.
Farm
Animals
15.6.3.1.2.1. Cattle
15.6.3.1.2.2. Swine
15.6.3.1.2.3. Poultry
15.6.3.1.2.4. Horse
15.6.3.1.2.5. Others
15.6.3.2.
Egypt Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product Type
15.6.3.2.1.
Testing
kits
15.6.3.2.2.
Reagents
15.6.3.3.
Egypt Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases Type
15.6.3.3.1.
Inflammatory
Diseases
15.6.3.3.2.
Infectious
Diseases
15.6.3.3.3.
Cardiovascular
Diseases
15.6.3.3.4.
Tumors
15.6.3.3.5.
Others
15.6.3.4.
Egypt Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.3.4.1.
Veterinary
Hospitals
15.6.3.4.2.
Veterinary
Clinics
15.6.3.4.3.
Research
Centers
15.6.3.4.4.
Others
15.6.4. Kuwait
15.6.4.1.
Kuwait Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal Type
15.6.4.1.1.
Companion
Animals
15.6.4.1.1.1. Dogs
15.6.4.1.1.2. Cats
15.6.4.1.1.3. Others
15.6.4.1.2.
Farm
Animals
15.6.4.1.2.1. Cattle
15.6.4.1.2.2. Swine
15.6.4.1.2.3. Poultry
15.6.4.1.2.4. Horse
15.6.4.1.2.5. Others
15.6.4.2.
Kuwait Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product Type
15.6.4.2.1.
Testing
kits
15.6.4.2.2.
Reagents
15.6.4.3.
Kuwait Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases Type
15.6.4.3.1.
Inflammatory
Diseases
15.6.4.3.2.
Infectious
Diseases
15.6.4.3.3.
Cardiovascular
Diseases
15.6.4.3.4.
Tumors
15.6.4.3.5.
Others
15.6.4.4.
Kuwait Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.4.4.1.
Veterinary
Hospitals
15.6.4.4.2.
Veterinary
Clinics
15.6.4.4.3.
Research
Centers
15.6.4.4.4.
Others
15.6.5. South Africa
15.6.5.1.
South
Africa Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal
Type
15.6.5.1.1.
Companion
Animals
15.6.5.1.1.1. Dogs
15.6.5.1.1.2. Cats
15.6.5.1.1.3. Others
15.6.5.1.2.
Farm
Animals
15.6.5.1.2.1. Cattle
15.6.5.1.2.2. Swine
15.6.5.1.2.3. Poultry
15.6.5.1.2.4. Horse
15.6.5.1.2.5. Others
15.6.5.2.
South
Africa Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product
Type
15.6.5.2.1.
Testing
kits
15.6.5.2.2.
Reagents
15.6.5.3.
South
Africa Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases
Type
15.6.5.3.1.
Inflammatory
Diseases
15.6.5.3.2.
Infectious
Diseases
15.6.5.3.3.
Cardiovascular
Diseases
15.6.5.3.4.
Tumors
15.6.5.3.5.
Others
15.6.5.4.
South
Africa Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By End
Users
15.6.5.4.1.
Veterinary
Hospitals
15.6.5.4.2.
Veterinary
Clinics
15.6.5.4.3.
Research
Centers
15.6.5.4.4.
Others
15.6.6. Rest of Middle East & Africa
15.6.6.1.
Rest of
Middle East & Africa Veterinary Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Animal Type
15.6.6.1.1.
Companion
Animals
15.6.6.1.1.1. Dogs
15.6.6.1.1.2. Cats
15.6.6.1.1.3. Others
15.6.6.1.2.
Farm
Animals
15.6.6.1.2.1. Cattle
15.6.6.1.2.2. Swine
15.6.6.1.2.3. Poultry
15.6.6.1.2.4. Horse
15.6.6.1.2.5. Others
15.6.6.2.
Rest of
Middle East & Africa Veterinary Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Product Type
15.6.6.2.1.
Testing
kits
15.6.6.2.2.
Reagents
15.6.6.3.
Rest of
Middle East & Africa Veterinary Biomarkers Market Revenue (US$ Mn) and
Forecasts, By Diseases Type
15.6.6.3.1.
Inflammatory
Diseases
15.6.6.3.2.
Infectious
Diseases
15.6.6.3.3.
Cardiovascular
Diseases
15.6.6.3.4.
Tumors
15.6.6.3.5.
Others
15.6.6.4.
Rest of
Middle East & Africa Veterinary Biomarkers Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.6.4.1.
Veterinary
Hospitals
15.6.6.4.2.
Veterinary
Clinics
15.6.6.4.3.
Research
Centers
15.6.6.4.4.
Others
15.7. Key Segment for Channeling Investments
15.7.1. By Country
15.7.2. By Animal Type
15.7.3. By Product Type
15.7.4. By Diseases Type
15.7.5. By End Users
16. Latin America Veterinary Biomarkers Market
Analysis and Forecasts, 2022 - 2030
16.1. Overview
16.1.1. Latin America Veterinary Biomarkers Market
Revenue (US$ Mn)
16.2. Latin America Veterinary Biomarkers Market
Revenue (US$ Mn) and Forecasts, By Animal Type
16.2.1. Companion Animals
16.2.1.1.
Dogs
16.2.1.2.
Cats
16.2.1.3.
Others
16.2.2. Farm Animals
16.2.2.1.
Cattle
16.2.2.2.
Swine
16.2.2.3.
Poultry
16.2.2.4.
Horse
16.2.2.5.
Others
16.3. Latin America Veterinary Biomarkers Market
Revenue (US$ Mn) and Forecasts, By Product Type
16.3.1. Testing kits
16.3.2. Reagents
16.4. Latin America Veterinary Biomarkers Market
Revenue (US$ Mn) and Forecasts, By Diseases Type
16.4.1. Inflammatory Diseases
16.4.2. Infectious Diseases
16.4.3. Cardiovascular Diseases
16.4.4. Tumors
16.4.5. Others
16.5. Latin America Veterinary Biomarkers Market
Revenue (US$ Mn) and Forecasts, By End Users
16.5.1. Veterinary Hospitals
16.5.2. Veterinary Clinics
16.5.3. Research Centers
16.5.4. Others
16.6. Latin America Veterinary Biomarkers Market
Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1.
Brazil Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal Type
16.6.1.1.1.
Companion
Animals
16.6.1.1.1.1. Dogs
16.6.1.1.1.2. Cats
16.6.1.1.1.3. Others
16.6.1.1.2.
Farm
Animals
16.6.1.1.2.1. Cattle
16.6.1.1.2.2. Swine
16.6.1.1.2.3. Poultry
16.6.1.1.2.4. Horse
16.6.1.1.2.5. Others
16.6.1.2.
Brazil Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product Type
16.6.1.2.1.
Testing
kits
16.6.1.2.2.
Reagents
16.6.1.3.
Brazil Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases Type
16.6.1.3.1.
Inflammatory
Diseases
16.6.1.3.2.
Infectious
Diseases
16.6.1.3.3.
Cardiovascular
Diseases
16.6.1.3.4.
Tumors
16.6.1.3.5.
Others
16.6.1.4.
Brazil Veterinary
Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
16.6.1.4.1.
Veterinary
Hospitals
16.6.1.4.2.
Veterinary
Clinics
16.6.1.4.3.
Research
Centers
16.6.1.4.4.
Others
16.6.2. Argentina
16.6.2.1.
Argentina
Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Animal Type
16.6.2.1.1.
Companion
Animals
16.6.2.1.1.1. Dogs
16.6.2.1.1.2. Cats
16.6.2.1.1.3. Others
16.6.2.1.2.
Farm Animals
16.6.2.1.2.1. Cattle
16.6.2.1.2.2. Swine
16.6.2.1.2.3. Poultry
16.6.2.1.2.4. Horse
16.6.2.1.2.5. Others
16.6.2.2.
Argentina
Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Product Type
16.6.2.2.1.
Testing
kits
16.6.2.2.2.
Reagents
16.6.2.3.
Argentina
Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By Diseases Type
16.6.2.3.1.
Inflammatory
Diseases
16.6.2.3.2.
Infectious
Diseases
16.6.2.3.3.
Cardiovascular
Diseases
16.6.2.3.4.
Tumors
16.6.2.3.5.
Others
16.6.2.4.
Argentina
Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By End Users
16.6.2.4.1.
Veterinary
Hospitals
16.6.2.4.2.
Veterinary
Clinics
16.6.2.4.3.
Research
Centers
16.6.2.4.4.
Others
16.6.3. Rest of Latin America
16.6.3.1.
Rest of
Latin America Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Animal Type
16.6.3.1.1.
Companion
Animals
16.6.3.1.1.1. Dogs
16.6.3.1.1.2. Cats
16.6.3.1.1.3. Others
16.6.3.1.2.
Farm
Animals
16.6.3.1.2.1. Cattle
16.6.3.1.2.2. Swine
16.6.3.1.2.3. Poultry
16.6.3.1.2.4. Horse
16.6.3.1.2.5. Others
16.6.3.2.
Rest of
Latin America Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Product Type
16.6.3.2.1.
Testing
kits
16.6.3.2.2.
Reagents
16.6.3.3.
Rest of
Latin America Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By
Diseases Type
16.6.3.3.1.
Inflammatory
Diseases
16.6.3.3.2.
Infectious
Diseases
16.6.3.3.3.
Cardiovascular
Diseases
16.6.3.3.4.
Tumors
16.6.3.3.5.
Others
16.6.3.4.
Rest of
Latin America Veterinary Biomarkers Market Revenue (US$ Mn) and Forecasts, By
End Users
16.6.3.4.1.
Veterinary
Hospitals
16.6.3.4.2.
Veterinary
Clinics
16.6.3.4.3.
Research
Centers
16.6.3.4.4.
Others
16.7. Key Segment for Channeling Investments
16.7.1. By Country
16.7.2. By Animal Type
16.7.3. By Product Type
16.7.4. By Diseases Type
16.7.5. By End Users
17. Competitive Benchmarking
17.1. Brand Benchmarking
17.2. Market Share Analysis, 2020
17.3. Global Presence and Growth Strategies
17.3.1. Mergers and Acquisitions
17.3.2. Product Launches
17.3.3. Investments Trends
17.3.4. R&D Initiatives
18. Player Profiles
18.1. ACUVET BIOTECH
18.1.1. Company Details
18.1.2. Company Overview
18.1.3. Product Offerings
18.1.4. Key Developments
18.1.5. Financial Analysis
18.1.6. SWOT Analysis
18.1.7. Business Strategies
18.2. Antech Diagnostics, Inc
18.2.1. Company Details
18.2.2. Company Overview
18.2.3. Product Offerings
18.2.4. Key Developments
18.2.5. Financial Analysis
18.2.6. SWOT Analysis
18.2.7. Business Strategies
18.3. Avacta Animal Health Limited
18.3.1. Company Details
18.3.2. Company Overview
18.3.3. Product Offerings
18.3.4. Key Developments
18.3.5. Financial Analysis
18.3.6. SWOT Analysis
18.3.7. Business Strategies
18.4. COBO SCIENTIFIC ApS
18.4.1. Company Details
18.4.2. Company Overview
18.4.3. Product Offerings
18.4.4. Key Developments
18.4.5. Financial Analysis
18.4.6. SWOT Analysis
18.4.7. Business Strategies
18.5. Diapharma
18.5.1. Company Details
18.5.2. Company Overview
18.5.3. Product Offerings
18.5.4. Key Developments
18.5.5. Financial Analysis
18.5.6. SWOT Analysis
18.5.7. Business Strategies
18.6. Life Diagnostics
18.6.1. Company Details
18.6.2. Company Overview
18.6.3. Product Offerings
18.6.4. Key Developments
18.6.5. Financial Analysis
18.6.6. SWOT Analysis
18.6.7. Business Strategies
18.7. Mercodia AB
18.7.1. Company Details
18.7.2. Company Overview
18.7.3. Product Offerings
18.7.4. Key Developments
18.7.5. Financial Analysis
18.7.6. SWOT Analysis
18.7.7. Business Strategies
18.8. Veterinary Biomarkers, Inc.
18.8.1. Company Details
18.8.2. Company Overview
18.8.3. Product Offerings
18.8.4. Key Developments
18.8.5. Financial Analysis
18.8.6. SWOT Analysis
18.8.7.
Business
Strategies
18.9. Zoetis
18.9.1. Company Details
18.9.2. Company Overview
18.9.3. Product Offerings
18.9.4. Key Developments
18.9.5. Financial Analysis
18.9.6. SWOT Analysis
18.9.7.
Business
Strategies
18.10. Other Market Participants
19. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.